Seysara

(Sarecycline)

Seysara

Drug updated on 11/16/2023

Dosage FormTablet (oral: 60 mg, 100 mg, 150 mg)
Drug ClassTetracycline class antibacterials
Ongoing and Completed StudiesClinicalTrials.gov

Indication

  • To treat inflammatory lesions of non-nodular moderate to severe acne vulgaris in patients ≥ 9 years of age.

Product Monograph / Prescribing Information

Document TitleYearSource
Seysara (sarecycline) Prescribing Information.2021Almirall LLC, Malvern, PA

Systematic Reviews / Meta-Analyses

Document TitleYearSource
Oral tetracyclines and acne: a systematic review for dermatologists.2020Journal of Drugs in Dermatology